Identification of the HLA-DQB1*06:144N Allele by Next-Generation Sequencing

Related Experiment Video

Updated: Feb 25, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.3K

Ruby J Siegel1, Katrin Hacke1, Rose M Ridgley1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.

HLA
|February 24, 2026
PubMed

Abstract:

HLA-DQB1*06:144N differs from HLA-DQB1*06:03:01:01 by one nucleotide substitution, introducing a premature stop codon in exon 2.

Keywords:
HLA‐DQB1*06:144Nnext‐generation sequencingnovel HLA allele

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K

Related Experiment Videos

Last Updated: Feb 25, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.3K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

99.4K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.4K

Articles linked to this work by shared authors, journal, and citation graph.

Identification of the Novel HLA-DRB1*03:234 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-C*07:1268 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-B*08:345Q Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-A*32:202 Allele by Next-Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Identification of the Novel HLA-DQB1*06:549 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-B*57:205 Allele by Next-Generation Sequencing.

HLA·2026

Evaluation of A Novel Point-of-Care Real-Time PCR Platform for Rapid Screening of HLA-B27 Using Whole Blood.

HLA·2026

Related and Unrelated Donor Match Presence for Haematopoietic Stem Cell Transplantation in a Portuguese HLA Referral Cohort.

HLA·2026

The Novel HLA-C*01:309 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual.

HLA·2026

Identification of a Novel HLA-G Allele, HLA-G*01:65, Using PolyseqOne and Oxford Nanopore Sequencing.

HLA·2026

Identification of the Novel HLA-B*35:670 Allele by Next-Generation Sequencing in a Bone Marrow Donor.

HLA·2026

GIST in Turner Syndrome.

ESMO gastrointestinal oncology·2026

Bazex-Dupré-Christol Syndrome Without Basal Cell Carcinoma Associated With a Large Interstitial Duplication at Xq26.1.

Genes, chromosomes & cancer·2026

Very Low Frequency of SCA27B Among Undiagnosed Cerebellar Ataxia Patients in Peru.

Cerebellum (London, England)·2026

A Case of Autosomal Dominant Alport Syndrome with Normal Type IV Collagen α5 Staining Diagnosed by a Genetic Analysis.

Internal medicine (Tokyo, Japan)·2026

Characterisation of the Novel HLA-DQB1*03:567 and HLA-DQB1*03:613 Alleles by Next-Generation Sequencing.

HLA·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us